[The clinical and pharmacokinetic results of intrapleural epirubicin application].
Schilcher
R B
RB
Abteilung für Strahlentherapie und Onkologie, Klinikum, J.-W.-Goethe-Universität, Frankfurt a. M.
Rahn
A N
AN
Scheulen
M E
ME
D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000493:pharmacokinetics; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism; D002408:Catheters, Indwelling; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D019300:Medical Errors; D010996:Pleural Effusion / Q000378:metabolism; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D015251:Epirubicin; D003520:Cyclophosphamide
Klinische und pharmakokinetische Ergebnisse intrapleuraler Epirubicin-Applikation.